The Korea government may face another investor-state dispute case from the Chinese capital if the license is called off.
In a letter to Congress, the groups demand that the pact’s giveaways to Big Pharma that would keep medicines unaffordable be removed before the pact is sent to Congress.
NAFTA 2.0 would effectively tie the US Congress’ hands in the struggle against rising drug prices.
The Intellectual Property Chapter of the revised NAFTA, rebranded by the Trump Administration USMCA, includes provisions that threaten to undermine critical efforts towards affordable health care and medicine.
Proposals from Japan and South Korea would require patent law changes in several RCEP countries, including Indonesia.
Multinational corporations are suing countries for using generic versions of life saving medicines.
We condemn the secretly negotiated Regional Comprehensive Economic Partnership (RCEP) which will erode people’s sovereignty and undermine health equity.
The German Supreme Court dismissed the original arbitration decision against Slovakia concerning the ban on health-insurance companies’ profits.
Canada’s negotiators extended data protection on biologics without knowing impact on prices.
Treasury minister was speaking on the same day the Cato Institute called for softer environmental rules and NHS competition.
Japan is planning to accept a greater number of caregivers from three Southeastern Asian countries having bilateral free trade agreements with Tokyo as part of efforts to address a labour shortage in the country.
A potential collision course between trade and investment agreements and public health measures could impact countries’ regulations of unhealthy food and drinks.
Two years after an FOI claim was lodged, the price of the six-year fight with Philip Morris has been revealed
Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade.
Trade Minister Steven Ciobo has promised to take a hard line with Europe on the question of cheap medicines and his counterpart Cecilia Malmström foresees “difficult” negotiations over Australian producers using European names such as "parmesan".
Groups say agreement will harm Thai agriculture and health, warn decision should be left to incoming elected government.
The Consumer Association of Penang (CAP) is urging the government to assess its position in regional trade agreements like the TPP and the RCEP.
Investor-State Dispute Settlement (ISDS) poses significant challenges in respect of tobacco control, public health, human rights, and sustainable development.
British microbiologists find that American technique at heart of Brexit trade row does not kill listeria and salmonella
The EU has apparently chosen to put the trade goals of European tobacco companies ahead of their own commitments to sustainable development.